| 1 | A1 | Human | M | 63 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2aN0M0 | 1 | II | |
| 1 | A2 | Human | M | 57 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T1N0M0 | 1 | I | |
| 1 | A3 | Human | F | 45 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T1N0M0 | 2 | I | |
| 1 | A4 | Human | M | 72 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2aN0M0 | 2 | II | |
| 1 | A5 | Human | M | 43 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T1N0M0 | 2 | I | |
| 1 | A6 | Human | F | 56 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T1N0M0 | 2 | I | |
| 1 | A7 | Human | F | 54 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | | 2 | | |
| 1 | A8 | Human | M | 66 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T1N0M0 | 2 | I | |
| 1 | A9 | Human | M | 60 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T1N0M0 | 2 | I | |
| 1 | A10 | Human | F | 79 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2N0M0 | 2 | II | |
| 1 | B1 | Human | M | 45 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2aN0M0 | 2 | II | |
| 1 | B2 | Human | M | 66 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2N0M0 | 2 | II | |
| 1 | B3 | Human | M | 45 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T3bN0M0 | 2 | III | |
| 1 | B4 | Human | M | 65 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2aN0M0 | 2 | II | |
| 1 | B5 | Human | M | 65 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2aN0M0 | 2 | II | |
| 1 | B6 | Human | M | 69 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T1N0M0 | 2 | I | |
| 1 | B7 | Human | F | 64 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2N0M0 | 2 | II | |
| 1 | B8 | Human | F | 58 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2bN0M0 | 2 | II | |
| 1 | B9 | Human | M | 50 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2aN0M0 | 2 | II | |
| 1 | B10 | Human | F | 47 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2bN0M0 | 2 | II | |
| 1 | C1 | Human | M | 38 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T1N0M0 | 1 | I | |
| 1 | C2 | Human | M | 45 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T1N0M0 | 1 | I | |
| 1 | C3 | Human | M | 42 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2aN0M0 | 2 | II | |
| 1 | C4 | Human | M | 68 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2N0M0 | 2 | II | |
| 1 | C5 | Human | M | 70 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2N0M0 | 2 | II | |
| 1 | C6 | Human | M | 65 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2aN0M0 | 2 | II | |
| 1 | C7 | Human | M | 68 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2aN0M0 | 3 | II | |
| 1 | C8 | Human | M | 58 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2N0M0 | 3 | II | |
| 1 | C9 | Human | M | 49 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T1N0M0 | 3 | I | |
| 1 | C10 | Human | F | 48 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2bN0M0 | 3 | II | |
| 1 | D1 | Human | M | 73 y | Bladder (Bla) | Squamous cell carcinoma | Malignant | T2N0M0 | 1 | II | |
| 1 | D2 | Human | M | 51 y | Bladder (Bla) | Squamous cell carcinoma | Malignant | T3aN0M0 | 1 | II | |
| 1 | D3 | Human | M | 74 y | Bladder (Bla) | Squamous cell carcinoma | Malignant | T2aN0M0 | 1 | II | |
| 1 | D4 | Human | M | 68 y | Bladder (Bla) | Squamous cell carcinoma | Malignant | T3aN0M0 | 1 | II | |
| 1 | D5 | Human | M | 67 y | Bladder (Bla) | Squamous cell carcinoma | Malignant | T3aN0M0 | 2 | II | |
| 1 | D6 | Human | M | 66 y | Bladder, Fibrous tissue and smooth muscle (Bla) | Adenocarcinoma | Malignant | T3bN0M0 | | III | |
| 1 | D7 | Human | M | 69 y | Bladder (Bla) | Adenocarcinoma with necrosis | Malignant | T3bN0M0 | 2-3 | III | |
| 1 | D8 | Human | M | 68 y | Bladder (Bla) | Carcinoma | Malignant | T3bN0M0 | | III | Undifferentiated |
| 1 | D9 | Human | M | 54 y | Bladder (Bla) | Carcinoma sarcomatodes | Malignant | T3aN0M0 | | II | |
| 1 | D10 | Human | M | 53 y | Bladder (Bla) | Carcinoma sarcomatodes | Malignant | T3bN0M0 | | III | |
| 1 | E1 | Human | F | 74 y | Bladder (Bla) | Carcinoma sarcomatodes | Malignant | T3bN0M0 | | III | |
| 1 | E2 | Human | M | 63 y | Abdomen (Abd) | Metastasis from bladder transitional cell carcinoma | Metastatic | | 2 | | |
| 1 | E3 | Human | F | 51 y | Abdomen (Abd) | Metastasis from bladder transitional cell carcinoma | Metastatic | | 2 | | |
| 1 | E4 | Human | M | 61 y | Brain, Cerebrum (Brn) | Metastasis from transitional cell carcinoma | Metastatic | | 3 | | |
| 1 | E5 | Human | M | 48 y | Bladder (Bla) | Transitional cell carcinoma, Papillary | Malignant | | | | |
| 1 | E6 | Human | M | 68 y | Bladder (Bla) | Transitional cell carcinoma, Papillary | Malignant | | | | |
| 1 | E7 | Human | M | 64 y | Bladder (Bla) | Transitional cell carcinoma, Papillary | Malignant | | | | |
| 1 | E8 | Human | M | 67 y | Bladder (Bla) | Pheochromocytoma | Tumor | | | | |
| 1 | E9 | Human | F | 37 y | Bladder (Bla) | Pheochromocytoma | Tumor | | | | |
| 1 | E10 | Human | M | 69 y | Bladder, Mucosa (Bla) | Hyperplasia | Diseased | | | | |
| 1 | F1 | Human | M | 58 y | Bladder, Mucosa (Bla) | Hyperplasia | Diseased | | | | |
| 1 | F2 | Human | M | 43 y | Bladder, Mucosa (Bla) | Hyperplasia | Diseased | | | | |
| 1 | F3 | Human | M | 50 y | Bladder, Mucosa (Bla) | Hyperplasia | Diseased | | | | |
| 1 | F4 | Human | M | 68 y | Bladder, Mucosa (Bla) | Hyperplasia | Diseased | | | | |
| 1 | F5 | Human | M | 54 y | Bladder, Mucosa (Bla) | Hyperplasia | Diseased | | | | |
| 1 | F6 | Human | M | 33 y | Bladder, Mucosa (Bla) | Hyperplasia | Diseased | | | | |
| 1 | F7 | Human | M | 47 y | Bladder, Mucosa (Bla) | Hyperplasia | Diseased | | | | |
| 1 | F8 | Human | M | 65 y | Bladder, Mucosa (Bla) | Hyperplasia | Diseased | | | | |
| 1 | F9 | Human | M | 44 y | Bladder, Mucosa, Fibrous tissue and blood vessel (Bla) | Hyperplasia | Diseased | | | | |
| 1 | F10 | Human | M | 62 y | Bladder (Bla) | Focal neoplasia | Tumor | | | | |
| 1 | G1 | Human | M | 55 y | Bladder, Mucosa (Bla) | Hyperplasia, Adenoid | Diseased | | | | |
| 1 | G2 | Human | M | 64 y | Bladder, Mucosa, Fibrous tissue (Bla) | Inflammation, Chronic | Inflammatory | | | | |
| 1 | G3 | Human | F | 48 y | Bladder, Mucosa, Fibrous tissue and smooth muscle (Bla) | Inflammation, Chronic | Inflammatory | | | | |
| 1 | G4 | Human | F | 71 y | Bladder, Mucosa, Fibrous tissue and smooth muscle (Bla) | Inflammation, Chronic | Inflammatory | | | | |
| 1 | G5 | Human | M | 55 y | Bladder, Mucosa (Bla) | Inflammation, Chronic with squamous metaplasia | Inflammatory | | | | |
| 1 | G6 | Human | M | 36 y | Bladder, Mucosa (Bla) | Inflammation, Chronic | Inflammatory | | | | |
| 1 | G7 | Human | M | 54 y | Bladder, Mucosa (Bla) | Inflammation, Chronic | Inflammatory | | | | |
| 1 | G8 | Human | F | 75 y | Bladder, Mucosa (Bla) | Inflammation, Chronic | Inflammatory | | | | |
| 1 | G9 | Human | F | 72 y | Bladder, Mucosa (Bla) | Inflammation, Chronic | Inflammatory | | | | |
| 1 | G10 | Human | M | 5 mo | Bladder, Mucosa (Bla) | Adjacent normal with cystitis | Diseased | | | | |
| 1 | H1 | Human | M | 35 y | Bladder, Fibrous tissue and smooth muscle (Bla) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | H2 | Human | M | 50 y | Bladder (Bla) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | H3 | Human | M | 22 y | Bladder (Bla) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | H4 | Human | F | 40 y | Bladder, Fibrous tissue and smooth muscle (Bla) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | H5 | Human | F | 15 y | Bladder (Bla) | Normal | Benign non-neoplastic | | | | |
| 1 | H6 | Human | F | 18 y | Bladder (Bla) | Normal | Benign non-neoplastic | | | | |
| 1 | H7 | Human | M | 43 y | Bladder (Bla) | Normal | Benign non-neoplastic | | | | |
| 1 | H8 | Human | F | 21 y | Bladder, Fibrous tissue and smooth muscle (Bla) | Normal | Benign non-neoplastic | | | | |
| 1 | H9 | Human | F | 21 y | Bladder (Bla) | Normal | Benign non-neoplastic | | | | |
| 1 | H10 | Human | F | 41 y | Bladder (Bla) | Normal | Benign non-neoplastic | | | | |